Literature DB >> 5050537

Depression of the antibody response to tetanus toxoid in mice infected with malaria parasites.

A Voller, D Gall, B R Manawadu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5050537

Source DB:  PubMed          Journal:  Z Tropenmed Parasitol        ISSN: 0044-359X


× No keyword cloud information.
  8 in total

1.  The effect of malaria on the relative affinity of mouse antiprotein antibody.

Authors:  M W Steward; A Voller
Journal:  Br J Exp Pathol       Date:  1973-04

2.  The immune reponse to type III pneumococcal polysaccharide in mice with malaria.

Authors:  N Wedderburn; B N Dracott
Journal:  Clin Exp Immunol       Date:  1977-04       Impact factor: 4.330

3.  Depressed antibody responses to a thymus-dependent antigen in toxoplasmosis.

Authors:  G T Strickland; P C Sayles
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

4.  Immunosuppression in murine malaria. II. The primary response to bovine serum albumin.

Authors:  J S McBride; H S Micklem
Journal:  Immunology       Date:  1977-08       Impact factor: 7.397

5.  Immunosuppression in murine malaria. I. Response to type III pneumococcal polysaccharide.

Authors:  J S McBride; H S Micklem; J M Ure
Journal:  Immunology       Date:  1977-05       Impact factor: 7.397

Review 6.  Sickness behaviour pushed too far--the basis of the syndrome seen in severe protozoal, bacterial and viral diseases and post-trauma.

Authors:  Ian A Clark; Alison C Budd; Lisa M Alleva
Journal:  Malar J       Date:  2008-10-14       Impact factor: 2.979

7.  Invited commentary on David Fedson's article.

Authors:  Ian Clark; Lisa Alleva
Journal:  Influenza Other Respir Viruses       Date:  2009-09       Impact factor: 4.380

8.  Head-to-Head Comparison of Soluble vs. Qβ VLP Circumsporozoite Protein Vaccines Reveals Selective Enhancement of NANP Repeat Responses.

Authors:  Farhat Khan; Mike Porter; Robert Schwenk; Margot DeBot; Philippe Saudan; Sheetij Dutta
Journal:  PLoS One       Date:  2015-11-16       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.